Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biotech analyst joins Forward Pharma as CFO

This article was originally published in Scrip

Executive Summary

Copenhagen, Denmark-based Forward Pharma, a biopharmaceutical company focused on a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis, has named Joel Sendek chief financial officer. Mr Sendek joins Forward Pharma from Stifel Financial where he was managing director, biotechnology, and led the firm's healthcare equity research group. Mr Sendek will serve as a key member of the executive team providing strategic leadership for the company's financial functions, and for its short and long-term financial objectives in support of the business strategy, Forward Pharma said.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts